81 related articles for article (PubMed ID: 27122216)
1. [Establish and analyze the predictive model of early stage brain metastases in patients with breast cancer].
Wang Q; Wu S; Sun B; Huang Z; Meng X; Huang Y
Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(48):3927-9. PubMed ID: 27122216
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer.
Gabos Z; Sinha R; Hanson J; Chauhan N; Hugh J; Mackey JR; Abdulkarim B
J Clin Oncol; 2006 Dec; 24(36):5658-63. PubMed ID: 17102066
[TBL] [Abstract][Full Text] [Related]
4. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
Bartlett JM; Ellis IO; Dowsett M; Mallon EA; Cameron DA; Johnston S; Hall E; A'Hern R; Peckitt C; Bliss JM; Johnson L; Barrett-Lee P; Ellis P
J Clin Oncol; 2007 Oct; 25(28):4423-30. PubMed ID: 17906205
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors of brain metastasis in patients with breast cancer.
Xue J; Peng G; Yang JS; Ding Q; Cheng J
Med Oncol; 2013 Mar; 30(1):337. PubMed ID: 23400960
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab.
Tonyali O; Coskun U; Yuksel S; Inanc M; Bal O; Akman T; Yazilitas D; Ulas A; Kucukoner M; Aksoy A; Demirci U; Uysal M; Tanriverdi O; Gunaydin Y; Sumbul AT; Yildiz R; Karaca H; Oksuzoglu B; Ciltas A; Buyukberber S; Benekli M;
Breast; 2016 Feb; 25():22-6. PubMed ID: 26801412
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value].
Zhao J; Zhou R; Zhang Q; Shu P; Li H; Wang X; Shen Z; Liu F; Chen W; Qin J; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):47-52. PubMed ID: 28105619
[TBL] [Abstract][Full Text] [Related]
8. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
9. p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer.
Clahsen PC; van de Velde CJ; Duval C; Pallud C; Mandard AM; Delobelle-Deroide A; van den Broek L; Sahmoud TM; van de Vijver MJ
J Clin Oncol; 1998 Feb; 16(2):470-9. PubMed ID: 9469330
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
11. Recurrence in breast cancer. Analysis with frailty model.
Gohari MR; Mahmoudi M; Mohammed K; Pasha E; Khodabakhshi R
Saudi Med J; 2006 Aug; 27(8):1187-93. PubMed ID: 16883450
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for brain relapse in HER2-positive metastatic breast cancer patients.
Duchnowska R; Dziadziuszko R; Czartoryska-Arłukowicz B; Radecka B; Szostakiewicz B; Sosińska-Mielcarek K; Karpińska A; Starosławska E; Kubiatowski T; Szczylik C
Breast Cancer Res Treat; 2009 Sep; 117(2):297-303. PubMed ID: 19130219
[TBL] [Abstract][Full Text] [Related]
13. Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone.
Kurebayashi J; Kanomata N; Shimo T; Yamashita T; Aogi K; Nishimura R; Shimizu C; Tsuda H; Moriya T; Sonoo H
Breast Cancer; 2014 Mar; 21(2):214-22. PubMed ID: 22689016
[TBL] [Abstract][Full Text] [Related]
14. Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer.
Graesslin O; Abdulkarim BS; Coutant C; Huguet F; Gabos Z; Hsu L; Marpeau O; Uzan S; Pusztai L; Strom EA; Hortobagyi GN; Rouzier R; Ibrahim NK
J Clin Oncol; 2010 Apr; 28(12):2032-7. PubMed ID: 20308667
[TBL] [Abstract][Full Text] [Related]
15. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
16. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
[TBL] [Abstract][Full Text] [Related]
17. Predicting local recurrence following breast-conserving treatment: parenchymal signal enhancement ratio (SER) around the tumor on preoperative MRI.
Kim MY; Cho N; Koo HR; Yun BL; Bae MS; Chie EK; Moon WK
Acta Radiol; 2013 Sep; 54(7):731-8. PubMed ID: 23550189
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting the prognosis of breast cancer patients with brain metastases.
Saip P; Cicin I; Eralp Y; Kucucuk S; Tuzlali S; Karagol H; Aslay I; Topuz E
Breast; 2008 Oct; 17(5):451-8. PubMed ID: 18455400
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis.
Altundag K; Bondy ML; Mirza NQ; Kau SW; Broglio K; Hortobagyi GN; Rivera E
Cancer; 2007 Dec; 110(12):2640-7. PubMed ID: 17960791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
